The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Abstract
Human carbonic anhydrase (CA) IX is a tumor‐associated protein, since it is scarcely present in normal tissues, but highly overexpressed in a large number of solid tumors, where it actively contributes to survival and metastatic spread of tumor cells. Due to these features, the characterization of its biochemical, structural, and functional features for drug design purposes has been extensively carried out, with consequent development of several highly selective small molecule inhibitors and monoclonal antibodies to be used for different purposes. Aim of this review is to provide a comprehensive state‐of‐the‐art of studies performed on this enzyme, regarding structural, functional, and biomedical aspects, as well as the development of molecules with diagnostic and therapeutic applications for cancer treatment. A brief description of additional pharmacologic applications for CA IX inhibition in other diseases, such as arthritis and ischemia, is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Supuran, C. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2467 · Cited by 3,192
Self-citationInterfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
Self-citationHypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,491
Alterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012) · Chemical Reviews · doi:10.1021/cr200176r · Cited by 1,238
Self-citationCauses and consequences of tumour acidity and implications for treatment
Stubbs, M., McSheehy, P. M. J., Griffiths, J. R., & Bashford, C. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01615-9 · Cited by 778
Lou, Y., McDonald, P. C., Oloumi, A., Chia, S., Ostlund, C., Ahmadi, A., Kyle, A., auf dem Keller, U., Leung, S., Huntsman, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4261 · Cited by 755
Self-citationChiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2470 · Cited by 750
How many carbonic anhydrase inhibition mechanisms exist?
Supuran, C. T. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1122001 · Cited by 737
Self-citationHypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Self-citationExpression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer
Ivanov, S., Liao, S.-Y., Ivanova, A., Danilkovitch-Miagkova, A., Tarasova, N., Weirich, G., Merrill, M. J., Proescholdt, M. A., Oldfield, E. H., Lee, J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64038-2 · Cited by 679
Structure-based drug discovery of carbonic anhydrase inhibitors
Supuran, C. T. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.672983 · Cited by 614
Self-citationTumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
Regulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539
Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Maresca, A., Temperini, C., Vu, H., Pham, N. B., Poulsen, S.-A., Scozzafava, A., Quinn, R. J., & Supuran, C. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809683v · Cited by 521
Self-citationCrystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX
Alterio, V., Hilvo, M., Di Fiore, A., Supuran, C. T., Pan, P., Parkkila, S., Scaloni, A., Pastorek, J., Pastorekova, S., Pedone, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908301106 · Cited by 521
Self-citationPacchiano, F., Carta, F., McDonald, P. C., Lou, Y., Vullo, D., Scozzafava, A., Dedhar, S., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101541x · Cited by 519
Self-citationPastorek, J., Pastoreková, S., Callebaut, I., Mornon, J., Zelnı́k, V., Opavský, R., Zaťovičová, M., Liao, S., Portetelle, D., & Stanbridge, E. J. (1994) · PubMed · Cited by 509
MINI REVIEW Keratan sulfate: structure, biosynthesis, and function
Funderburgh, J. L. (2000) · Glycobiology · doi:10.1093/glycob/10.10.951 · Cited by 451
Oxygen availability and metabolic adaptations
Nakazawa, M. S., Keith, B., & Simon, M. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.84 · Cited by 435
Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., & Harris, A. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3660 · Cited by 432
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 417
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Supuran, C. T. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1253677 · Cited by 413
Self-citationDeciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins
Maresca, A., Temperini, C., Pochet, L., Masereel, B., Scozzafava, A., & Supuran, C. T. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901287j · Cited by 402
Self-citationOpavský, R., Pastoreková, S., Zelnı́k, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., Kettmann, R., & Pastorek, J. (1996) · Genomics · doi:10.1006/geno.1996.0223 · Cited by 384
Tu, C., Silverman, D. N., Forsman, C., Jonsson, B. H., & Lindskog, S. (1989) · Biochemistry · doi:10.1021/bi00445a054 · Cited by 376
Pastorekova, S., Parkkila, S., Parkkila, A., Opavsky, R., Zelnik, V, Saarnio, J., & Pastorek, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024293 · Cited by 351
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
Lock, F. E., McDonald, P. C., Lou, Y., Serrano, I., Chafe, S. C., Ostlund, C., Aparicio, S., Winum, J.-Y., Supuran, C. T., & Dedhar, S. (2013) · Oncogene · doi:10.1038/onc.2012.550 · Cited by 348
Self-citationSignalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 341
Giatromanolaki, A. N., Koukourakis, M. I., Sivridis, E., Pastorek, J., Wykoff, C. C., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 336
Whittington, D. A., Waheed, A., Ulmasov, B., Shah, G. N., Grubb, J. H., Sly, W. S., & Christianson, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161301298 · Cited by 335
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
Pastorek, J., & Pastorekova, S. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.08.002 · Cited by 328
Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes
Hilvo, M., Baranauskiene, L., Salzano, A. M., Scaloni, A., Matulis, D., Innocenti, A., Scozzafava, A., Monti, S. M., Di Fiore, A., De Simone, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800938200 · Cited by 307
Self-citationA Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
Krall, N., Pretto, F., Decurtins, W., Bernardes, G. J. L., Supuran, C. T., & Neri, D. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310709 · Cited by 299
Self-citationA novel quasi-viral agent, MaTu, is a two-component system
Pastoreková, S., Závadová, Z., Košťál, M., Babušíková, O., & Závada, J. (1992) · Virology · doi:10.1016/0042-6822(92)90464-z · Cited by 287
Carbonic Anhydrases: Role in pH Control and Cancer
Mboge, M., Mahon, B., McKenna, R., & Frost, S. (2018) · Metabolites · doi:10.3390/metabo8010019 · Cited by 281
Potter, C., & Harris, A. L. (2004) · Cell Cycle · doi:10.4161/cc.3.2.618 · Cited by 279
Saarnio, J., Parkkila, S., Parkkila, A.-K., Haukipuro, K., Pastoreková, S., Pastorek, J., Kairaluoma, M. I., & Karttunen, T. J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65569-1 · Cited by 270
Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013)
Monti, S. M., Supuran, C. T., & De Simone, G. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.798648 · Cited by 265
Self-citationExploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors
De Simone, G., Alterio, V., & Supuran, C. T. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.795145 · Cited by 258
Self-citationTouisni, N., Maresca, A., McDonald, P. C., Lou, Y., Scozzafava, A., Dedhar, S., Winum, J.-Y., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200983e · Cited by 253
Self-citationKaluz, S., Kaluzová, M., Liao, S.-Y., Lerman, M., & Stanbridge, E. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.01.001 · Cited by 248
Liao, S., Aurelio, O. N., Jan, K., Závada, J., & Stanbridge, E. J. (1997) · PubMed · Cited by 248
Microenvironmental and cellular consequences of altered blood flow in tumours
Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003) · The British Journal of Radiology · doi:10.1259/bjr/12913493 · Cited by 240
Švastová, E., Žilka, N., Zat'ovičová, M., Gibadulinová, A., Čiampor, F., Pastorek, J., & Pastoreková, S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00351-3 · Cited by 239
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
Supuran, C. T. (2017) · Metabolites · doi:10.3390/metabo7030048 · Cited by 232
Self-citationEntrapment of Carbon Dioxide in the Active Site of Carbonic Anhydrase II
Domsic, J. F., Avvaru, B. S., Kim, C. U., Gruner, S. M., Agbandje-McKenna, M., Silverman, D. N., & McKenna, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805353200 · Cited by 228
Innocenti, A., Beyza Öztürk Sarıkaya, S., Gülçin, İ., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.076 · Cited by 219
Self-citationCecchi, A., Hulikova, A., Pastorek, J., Pastoreková, S., Scozzafava, A., Winum, J.-Y., Montero, J.-L., & Supuran, C. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0501073 · Cited by 217
Self-citationPacchiano, F., Aggarwal, M., Avvaru, B. S., Robbins, A. H., Scozzafava, A., McKenna, R., & Supuran, C. T. (2010) · Chemical Communications · doi:10.1039/c0cc02707c · Cited by 217
Self-citationCarbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
De Simone, G., & Supuran, C. T. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.027 · Cited by 213
Self-citationThe von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities
Elias, R., Zhang, Q., & Brugarolas, J. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000480 · Cited by 205
The von Hippel–Lindau Tumor Suppressor Gene
Kondo, K., & Kaelin, W. G. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5139 · Cited by 203
Alterio, V., Vitale, R. M., Monti, S. M., Pedone, C., Scozzafava, A., Cecchi, A., De Simone, G., & Supuran, C. T. (2006) · Journal of the American Chemical Society · doi:10.1021/ja061574s · Cited by 203
Self-citationVullo, D., Franchi, M., Gallori, E., Pastorek, J., Scozzafava, A., Pastorekova, S., & Supuran, C. T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00091-x · Cited by 201
Self-citationBoztaş, M., Çetinkaya, Y., Topal, M., Gülçin, İ., Menzek, A., Şahin, E., Tanc, M., & Supuran, C. T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501573b · Cited by 200
Self-citationInnocenti, A., Vullo, D., Scozzafava, A., & Supuran, C. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.077 · Cited by 198
Self-citationDubois, L., Lieuwes, N. G., Maresca, A., Thiry, A., Supuran, C. T., Scozzafava, A., Wouters, B. G., & Lambin, P. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.019 · Cited by 198
Self-citationSolvent-Mediated Proton Transfer in Catalysis by Carbonic Anhydrase
Silverman, D. N., & McKenna, R. (2007) · Accounts of Chemical Research · doi:10.1021/ar7000588 · Cited by 191
Wilkinson, B. L., Bornaghi, L. F., Houston, T. A., Innocenti, A., Vullo, D., Supuran, C. T., & Poulsen, S.-A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061320h · Cited by 189
Self-citationSvastova, E., Witarski, W., Csaderova, L., Kosik, I., Skvarkova, L., Hulikova, A., Zatovicova, M., Barathova, M., Kopacek, J., Pastorek, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286062 · Cited by 189
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
Oosterwijk, E., Bander, N. H., Divgi, C. R., Welt, S., Wakka, J. C., Finn, R. D., Carswell, E. A., Larson, S. M., Warnaar, S. O., & Fleuren, G. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.738 · Cited by 182
Wilkinson, B. L., Bornaghi, L. F., Houston, T. A., Innocenti, A., Supuran, C. T., & Poulsen, S.-A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060967z · Cited by 176
Self-citationDubois, L., Peeters, S., Lieuwes, N. G., Geusens, N., Thiry, A., Wigfield, S., Carta, F., Mcintyre, A., Scozzafava, A., Dogné, J.-M., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.045 · Cited by 173
Self-citationSaarnio, J., Parkkila, S., Parkkila, A.-K., Waheed, A., Casey, M. C., Zhou, X. Y., Pastoreková, S., Pastorek, J., Karttunen, T., Haukipuro, K., et al. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600409 · Cited by 171
Závada, J., Závadová, Z., Pastorek, J., Biesová, Z., Jez˘ek, J., & Velek, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1111 · Cited by 170
Antimetastatic Effect of Sulfamate Carbonic Anhydrase IX Inhibitors in Breast Carcinoma Xenografts
Gieling, R. G., Babur, M., Mamnani, L., Burrows, N., Telfer, B. A., Carta, F., Winum, J.-Y., Scozzafava, A., Supuran, C. T., & Williams, K. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300529u · Cited by 166
Self-citationFisher, S. Z., Maupin, C. M., Budayova-Spano, M., Govindasamy, L., Tu, C., Agbandje-McKenna, M., Silverman, D. N., Voth, G. A., & McKenna, R. (2007) · Biochemistry · doi:10.1021/bi062066y · Cited by 166
The role of carbonic anhydrase IX overexpression in kidney cancer
Dorai, T., Sawczuk, I. S., Pastorek, J., Wiernik, P. H., & Dutcher, J. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.011 · Cited by 163
Maresca, A., Scozzafava, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.094 · Cited by 161
Self-citationCarbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I–XV
Innocenti, A., Gülçin, I., Scozzafava, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.038 · Cited by 160
Self-citationMenchise, V., De Simone, G., Alterio, V., Di Fiore, A., Pedone, C., Scozzafava, A., & Supuran, C. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050333c · Cited by 159
Self-citationDubois, L. J., Douma, K., Supuran, C. T., Chiu, R. K., van Zandvoort, M. A. M. J., Pastoreková, S., Scozzafava, A., Wouters, B. G., & Lambin, P. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.018 · Cited by 154
Self-citationCasey, J. R., Morgan, P. E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031079w · Cited by 153
Self-citationDitte, P., Dequiedt, F., Švastová, E., Hulíková, A., Ohradanova‐Repic, A., Zaťovičová, M., Csáderová, L., Kopáček, J., Supuran, C. T., Pastoreková, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2520 · Cited by 152
Self-citationStams, T., Nair, S. K., Okuyama, T., Waheed, A., Sly, W. S., & Christianson, D. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13589 · Cited by 151
Pastoreková, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.029 · Cited by 150
Self-citationGaraj, V., Puccetti, L., Fasolis, G., Winum, J., Montero, J., Scozzafava, A., Vullo, D., Innocenti, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.056 · Cited by 149
Self-citationNuclear Translocation of Cell‐Surface Receptors: Lessons from Fibroblast Growth Factor
Bryant, D. M., & Stow, J. (2005) · Traffic : the International Journal of Intracellular Transport · doi:10.1111/j.1600-0854.2005.00332.x · Cited by 145
Maresca, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.040 · Cited by 144
Self-citationIlies, M. A., Vullo, D., Pastorek, J., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021123s · Cited by 143
Scozzafava, A., Passaponti, M., Supuran, C. T., & Gülçın, İ. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.956310 · Cited by 142
Self-citationSelection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds
Buller, F., Steiner, M., Frey, K., Mircsof, D., Scheuermann, J., Kalisch, M., Bühlmann, P., Supuran, C. T., & Neri, D. (2010) · ACS Chemical Biology · doi:10.1021/cb1003477 · Cited by 140
Self-citationFiaschi, T., Giannoni, E., Taddei, L., Cirri, P., Marini, A., Pintus, G., Nativi, C., Richichi, B., Scozzafava, A., Carta, F., et al. (2013) · Cell Cycle · doi:10.4161/cc.24902 · Cited by 139
Self-citationBua, S., Mannelli, L. D. C., Vullo, D., Ghelardini, C., Bartolucci, G., Scozzafava, A., Supuran, C. T., & Carta, F. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01607 · Cited by 136
Self-citationColpaert, C., Vermeulen, P., Fox, S. B., Harris, A. L., Dirix, L. Y., & Marck, E. A. V. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1025702330207 · Cited by 133
Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
Shin, H., Rho, S. B., Jung, D. C., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.072207 · Cited by 132
Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9
Gut, M. O., Parkkila, S., Vernerová, Z., Rohde, E., Závada, J., Höcker, M. R., Pastorek, J., Karttunen, T. J., Gibadulinová, A., Závadová, Z., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.37052 · Cited by 131
Swayampakula, M., McDonald, P. C., Vallejo, M., Coyaud, E., Chafe, S. C., Westerback, A., Venkateswaran, G., Shankar, J., Gao, G., Laurent, E. M. N., et al. (2017) · Oncogene · doi:10.1038/onc.2017.219 · Cited by 130
Self-citationInnocenti, A., Vullo, D., Scozzafava, A., & Supuran, C. T. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.06.013 · Cited by 129
Self-citationZaťovičová, M., Jelenska, L., Hulíková, A., Csáderová, L., Ditte, Z., Ditte, P., Golias, T., Pastorek, J., & Pastoreková, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793429832 · Cited by 129
Morris, J. C., Chiche, J., Grellier, C., Lopez, M., Bornaghi, L. F., Maresca, A., Supuran, C. T., Pouysségur, J., & Poulsen, S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200892s · Cited by 128
Self-citationMoeker, J., Peat, T. S., Bornaghi, L. F., Vullo, D., Supuran, C. T., & Poulsen, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500255y · Cited by 124
Self-citationCarbonic Anhydrase IX as an Imaging and Therapeutic Target for Tumors and Metastases
Tafreshi, N. K., Lloyd, M. C., Bui, M. M., Gillies, R. J., & Morse, D. L. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_12 · Cited by 121
Can, D., Spingler, B., Schmutz, P., Mendes, F., Raposinho, P., Fernandes, C., Carta, F., Innocenti, A., Santos, I., Supuran, C. T., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107333 · Cited by 121
Self-citationPuccetti, L., Fasolis, G., Vullo, D., CHOHAN, Z. H., Scozzafava, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.055 · Cited by 120
Self-citationCarta, F., Maresca, A., Scozzafava, A., & Supuran, C. T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.014 · Cited by 118
Self-citationNocentini, A., Ferraroni, M., Carta, F., Ceruso, M., Gratteri, P., Lanzi, C., Masini, E., & Supuran, C. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01389 · Cited by 118
Self-citationPastoreková, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., & Supuran, C. T. (2004) · ChemInform · doi:10.1002/chin.200425244 · Cited by 118
Self-citationNatural product coumarins that inhibit human carbonic anhydrases
Davis, R. A., Vullo, D., Maresca, A., Supuran, C. T., & Poulsen, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.021 · Cited by 111
Self-citationStiti, M., Cecchi, A., Rami, M., Abdaoui, M., Barragan‐Montero, V., Scozzafava, A., Guari≠, Y., Winum, J., & Supuran, C. T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805558k · Cited by 110
Self-citationAhlskog, J., Schliemann, C., Mårlind, J., Qureshi, U., Ammar, A., Pedley, R. B., & Neri, D. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605200 · Cited by 110
The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration
Csáderová, L., Debreova, M., Radvák, P., Stano, M., Vrestiakova, M., Kopáček, J., Pastoreková, S., & Švastová, E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00271 · Cited by 108
Logsdon, D. P., Grimard, M., Luo, M., Shahda, S., Jiang, Y., Tong, Y., Yu, Z., Zyromski, N. J., Schipani, E., Carta, F., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0253 · Cited by 108
Self-citationGaraj, V., Puccetti, L., Fasolis, G., Winum, J., Montero, J., Scozzafava, A., Vullo, D., Innocenti, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.087 · Cited by 107
Self-citationSimone, G. D., Vitale, R. M., Fiore, A. D., Pedone, C., Scozzafava, A., Montero, J., Winum, J., & Supuran, C. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060531j · Cited by 106
Self-citationExpression of hypoxia-inducible carbonic anhydrases in brain tumors
Proescholdt, M. A., Mayer, C., Kubitza, M., Schubert, T. E. O., Liao, S., Stanbridge, E. J., Ivanov, S. V., Oldfield, E. H., Brawanski, A. T., & Merrill, M. J. (2005) · Neuro-Oncology · doi:10.1215/s1152851705000025 · Cited by 104
Mannelli, L. D. C., Micheli, L., Carta, F., Cozzi, A., Ghelardini, C., & Supuran, C. T. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1113407 · Cited by 103
Self-citationExpression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
Hynninen, P., Vaskivuo, L., Saarnio, J., Haapasalo, H. K., Kivelä, J., Pastoreková, S., Pastorek, J., Waheed, A., Sly, W. S., Puistola, U., et al. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02523.x · Cited by 101
Carta, F., Garaj, V., Maresca, A., Wagner, J. M., Avvaru, B. S., Robbins, A. H., Scozzafava, A., McKENNA, R. V., & Supuran, C. T. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.005 · Cited by 100
Self-citationGrandāne, A., Tanç, M., Mannelli, L. D. C., Carta, F., Ghelardini, C., Žalubovskis, R., & Supuran, C. T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00523 · Cited by 99
Self-citationElucidation of the Proton Transport Mechanism in Human Carbonic Anhydrase II
Maupin, C. M., McKENNA, R. V., Silverman, D. N., & Voth, G. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8091938 · Cited by 99
Ward, C., Meehan, J., Mullen, P., Supuran, C. T., Dixon, J. M., Thomas, J. S. J., Winum, J., Lambin, P., Dubois, L. J., Pavathaneni, N.-K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4498 · Cited by 99
Self-citationCarbonic anhydrase IX in bladder cancer
Klatte, T., Seligson, D. B., Rao, J. Y., Yu, H., de Martino, M., Kawaoka, K., Wong, S., Belldegrun, A. S., & Pantuck, A. J. (2009) · Cancer · doi:10.1002/cncr.24163 · Cited by 96
Jonathan, R. A., Wijffels, K. I. E. M., Peeters, W. J. M., de Wilde, P. C. M., Marres, H. A. M., Merkx, M. A. W., Oosterwijk, E., van der Kogel, A. J., & Kaanders, J. H. A. M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.04.008 · Cited by 95
Dubois, L. J., Peeters, S. G. J. A., van Kuijk, S. J. A., Yaromina, A., Lieuwes, N. G., Saraya, R., Biemans, R., Rami, M., Parvathaneni, N. K., Vullo, D., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.018 · Cited by 94
Self-citationRami, M., Dubois, L. J., Parvathaneni, N.-K., Alterio, V., van Kuijk, S. J. A., Monti, S. M., Lambin, P., Simone, G. D., Supuran, C. T., & Winum, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4009532 · Cited by 93
Self-citationAkurathi, V., Dubois, L. J., Lieuwes, N. G., Chitneni, S. K., Cleynhens, B. J., Vullo, D., Supuran, C. T., Verbruggen, A., Lambin, P., & Bormans, G. M. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.02.006 · Cited by 92
Self-citationGieling, R. G., Parker, C. A., Costa, L. A. D., Robertson, N., Harris, A. L., Stratford, I. J., & Williams, K. J. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.736979 · Cited by 92
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis
Andreucci, E., Peppicelli, S., Carta, F., Brisotto, G., Biscontin, E., Ruzzolini, J., Bianchini, F., Biagioni, A., Supuran, C. T., & Calorini, L. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1590-9 · Cited by 92
Self-citationThe Catalytic Properties of Human Carbonic Anhydrase IX
Wingo, T. S., Tu, C., Laipis, P. J., & Silverman, D. N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5824 · Cited by 90
Saccharin: A lead compound for structure-based drug design of carbonic anhydrase IX inhibitors
Mahon, B. P., Hendon, A. M., Driscoll, J. M., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.030 · Cited by 82
7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors
Tanç, M., Carta, F., Bozdağ, M., Scozzafava, A., & Supuran, C. T. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.032 · Cited by 77
Self-citationInnocenti, A., Pastoreková, S., Pastorek, J., Scozzafava, A., Simone, G. D., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.088 · Cited by 76
Self-citationZat'ovičová, M., Tarábková, K., Švastová, E., Gibadulinová, A., Mucha, V., Jakubı&#x;čková, L., Biesová, Z., Rafajová, M., Gut, M. O., Parkkila, S., et al. (2003) · Journal of Immunological Methods · doi:10.1016/j.jim.2003.08.011 · Cited by 75
Pan, J., Lau, J., Mesak, F., Hundal-Jabal, N., Pourghiasian, M., Liu, Z., Bénard, F., Dedhar, S., Supuran, C. T., & Lin, K. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2013.773994 · Cited by 74
Self-citationAkocak, S., Alam, M. R., Shabana, A. M., Sanku, R. K. K., Vullo, D., Thompson, H., Swenson, E. R., Supuran, C. T., & Ilies, M. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00492 · Cited by 74
Self-citationA 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo
Krall, N., Pretto, F., Mattarella, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170514 · Cited by 74
Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
Oosterwijk‐Wakka, J. C., Boerman, O. C., Mulders, P., & Oosterwijk, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140611402 · Cited by 73
5- and 6-Membered (thio)lactones are prodrug type carbonic anhydrase inhibitors
Carta, F., Maresca, A., Scozzafava, A., & Supuran, C. T. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.018 · Cited by 70
Self-citationCarbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms
Supuran, C. T. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9271-4 · Cited by 69
Self-citationWinum, J., Carta, F., Ward, C., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.083 · Cited by 69
Self-citationParkkila, S., Innocenti, A., Kallio, H. M. L., Hilvo, M., Scozzafava, A., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.002 · Cited by 69
Self-citationCarbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates
Innocenti, A., Vullo, D., Scozzafava, A., Casey, J. R., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.057 · Cited by 68
Self-citationIsatin: a privileged scaffold for the design of carbonic anhydrase inhibitors
Melis, C., Meleddu, R., Angeli, A., Distinto, S., Bianco, G., Capasso, C., Cottiglia, F., Angius, R., Supuran, C. T., & Maccioni, E. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1235042 · Cited by 68
Self-citationThe Structure of Carbonic Anhydrase IX Is Adapted for Low-pH Catalysis
Mahon, B. P., Bhatt, A., Socorro, L., Driscoll, J. M., Okoh, C., Lomelino, C. L., Mboge, M. Y., Kurian, J. J., Tu, C., Agbandje‐McKenna, M., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00243 · Cited by 62
Identification of Proton-Transfer Pathways in Human Carbonic Anhydrase II
Roy, A., & Taraphder, S. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp073499t · Cited by 60
Groves, K., Bao, B., Zhang, J., Handy, E. L., Kennedy, P., Cuneo, G., Supuran, C. T., Yared, W., Peterson, J. D., & Rajopadhye, M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.058 · Cited by 58
Self-citationInhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells
Meehan, J., Ward, C., Turnbull, A., Wills, J. C., Finch, A. J., Jarman, E. J., Xintaropoulou, C., Martínez-Pérez, C., Gray, M., Pearson, M. W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17143 · Cited by 58
Self-citationAkurathi, V., Dubois, L. J., Celen, S., Lieuwes, N. G., Chitneni, S. K., Cleynhens, B. J., Innocenti, A., Supuran, C. T., Verbruggen, A., Lambin, P., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.027 · Cited by 57
Self-citationGrandāne, A., Tanç, M., Žalubovskis, R., & Supuran, C. T. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.01.043 · Cited by 57
Self-citationCarta, F., Vullo, D., Maresca, A., Scozzafava, A., & Supuran, C. T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.019 · Cited by 56
Self-citationBrockton, N. T., Klimowicz, A. C., Bose, P., Petrillo, S. K., Konno, M., Rudmik, L. R., Dean, M. L., Nakoneshny, S. C., Matthews, T. W., Chandarana, S. P., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.01.018 · Cited by 56
Carta, F., Vullo, D., Maresca, A., Scozzafava, A., & Supuran, C. T. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.129 · Cited by 56
Self-citationLau, J., Zhang, Z., Jenni, S., Kuo, H., Liu, Z., Vullo, D., Supuran, C. T., Lin, K., & Bénard, F. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00934 · Cited by 55
Self-citation[18F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models
Peeters, S. G. J. A., Dubois, L. J., Lieuwes, N. G., Laan, D., Mooijer, M. P. J., Schuit, R. C., Vullo, D., Supuran, C. T., Eriksson, J., Windhorst, A. D., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0831-y · Cited by 54
Self-citationCarbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
Monti, S. M., Supuran, C. T., & Simone, G. D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799034851 · Cited by 54
Self-citationCleven, A. H. G., van Engeland, M., Wouters, B. G., & de Bruïne, A. P. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/945802 · Cited by 53
Pilka, E. S., Kochan, G. T., Oppermann, U. C. T., & Yue, W. W. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.038 · Cited by 53
New natural product carbonic anhydrase inhibitors incorporating phenol moieties
Karioti, A., Ceruso, M., Carta, F., Bilia, A. R., & Supuran, C. T. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.10.018 · Cited by 53
Self-citationKumar, R., Sharma, V., Bua, S., Supuran, C. T., & Sharma, P. K. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1367775 · Cited by 53
Self-citationGüzel-Akdemir, Ö., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., & Supuran, C. T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.110 · Cited by 52
Self-citationRadvák, P., Repic, M., Švastová, E., Takáčová, M., Csáderová, L., Strnad, H., Pastorek, J., Pastoreková, S., & Kopáček, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2226 · Cited by 52
Nakao, M., Ishii, G., Nagai, K., Kawase, A., Kenmotsu, H., Konno, H., Hishida, T., Nishimura, M., Yoshida, J., & Ochiai, A. (2009) · Cancer · doi:10.1002/cncr.24303 · Cited by 52
Nocentini, A., Ceruso, M., Carta, F., & Supuran, C. T. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1115401 · Cited by 52
Self-citationMarques, S. M., Enyedy, É. A., Supuran, C. T., Krupenko, N. I., Krupenko, S. A., & Santos, M. A. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.072 · Cited by 51
Self-citationBuanne, P., Renzone, G., Monteleone, F., Vitale, M., Monti, S. M., Sandomenico, A., Garbi, C., Montanaro, D., Accardo, M., Troncone, G., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300565w · Cited by 51
Self-citationLangella, E., D’Ambrosio, K., D’Ascenzio, M., Carradori, S., Monti, S. M., Supuran, C. T., & Simone, G. D. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201503748 · Cited by 51
Self-citationMollica, A., Costante, R., Akdemir, A., Carradori, S., Stefanucci, A., Macedonio, G., Ceruso, M., & Supuran, C. T. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.066 · Cited by 50
Self-citationCompain, G., Martin‐Mingot, A., Maresca, A., Thibaudeau, S., & Supuran, C. T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.037 · Cited by 49
Self-citationLopez, M., Paul, B., Hofmann, A., Morizzi, J., Wu, Q. K., Charman, S. A., Innocenti, A., Vullo, D., Supuran, C. T., & Poulsen, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900914e · Cited by 49
Self-citationN-Nitrosulfonamides: A new chemotype for carbonic anhydrase inhibition
Nocentini, A., Vullo, D., Bartolucci, G., & Supuran, C. T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.072 · Cited by 49
Self-citationGul, H. I., Mete, E., Eren, S. E., Sakagami, H., Yamalı, C., & Supuran, C. T. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1243536 · Cited by 49
Self-citationBozdağ, M., Alafeefy, A. M., Al-Tamimi, A.-M. S., Vullo, D., Carta, F., & Supuran, C. T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.039 · Cited by 48
Self-citationAntibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX
Murri-Plesko, M. T., Hulíková, A., Oosterwijk, E., Scott, A. M., Zortea, A., Harris, A. L., Ritter, G., Old, L. J., Bauer, S., Swietach, P., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.063 · Cited by 47
Zaťovičová, M., Jelenska, L., Hulíková, A., Ditte, P., Ditte, Z., Csáderová, L., Švastová, E., Schmalix, W. A., Böttger, V., Bevan, P., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2658 · Cited by 47
Winum, J., Pastoreková, S., Jakubicková, L., Montero, J., Scozzafava, A., Pastorek, J., Vullo, D., Innocenti, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.058 · Cited by 47
Self-citationBrockton, N. T., Dort, J. C., Lau, H., Hao, D., Brar, S., Klimowicz, A. C., Petrillo, S. K., Diaz, R., Doll, C., & Magliocco, A. M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.059 · Cited by 47
Angeli, A., Carta, F., Bartolucci, G., & Supuran, C. T. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.014 · Cited by 46
Self-citationSneddon, D., Niemans, R., Bauwens, M., Yaromina, A., van Kuijk, S. J. A., Lieuwes, N. G., Biemans, R., Pooters, I., Pellegrini, P. A., Lengkeek, N. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00623 · Cited by 45
Self-citationvan Dijk, J., Zegveld, S. T., Fleuren, G. J., & Warnaar, S. O. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480518 · Cited by 44
Brzozowski, Z., Slawinski, J. J., Sa̧czewski, F., Innocenti, A., & Supuran, C. T. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.02.020 · Cited by 44
Self-citationColinas, P. A., Bravo, R. D., Vullo, D., Scozzafava, A., & Supuran, C. T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.023 · Cited by 43
Self-citationFiore, A. D., Simone, G. D., Menchise, V., Pedone, C., Casini, A., Scozzafava, A., & Supuran, C. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.086 · Cited by 40
Self-citationSupuran, C. T., Fiore, A. D., Alterio, V., Monti, S. M., & Simone, G. D. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793429841 · Cited by 40
Self-citationPoly(amidoamine) Dendrimers with Carbonic Anhydrase Inhibitory Activity and Antiglaucoma Action
Carta, F., Osman, S. M., Vullo, D., Gullotto, A., Winum, J., ALOthman, Z. A., Masini, E., & Supuran, C. T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00383 · Cited by 40
Self-citationRami, M., Winum, J., Innocenti, A., Montero, J., Scozzafava, A., & Supuran, C. T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.025 · Cited by 39
Self-citationIlardi, G., Zambrano, N., Merolla, F., Siano, M., Varricchio, S., Vecchione, M. L., Rosa, G. D., Mascolo, M., & Staibano, S. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113209990227 · Cited by 39
Carradori, S., Mollica, A., Ceruso, M., D’Ascenzio, M., Monte, C. D., Chimenti, P., Sabia, R., Akdemir, A., & Supuran, C. T. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.05.013 · Cited by 36
Self-citationHulı́ková, A., Zaťovičová, M., Švastová, E., Ditte, P., Brasseur, R., Kettmann, R., Supuran, C. T., Kopáček, J., Pastorek, J., & Pastoreková, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.060 · Cited by 36
Self-citationSáenz‐de‐Santa‐María, I., Bernardo‐Castiñeira, C., Secades, P., Fernández, S. B. D. Q., Rodrigo, J. P., Astudillo, A., & Chiara, M. (2017) · Oncotarget · doi:10.18632/oncotarget.14629 · Cited by 33
van Kuijk, S. J. A., Parvathaneni, N. K., Niemans, R., van Gisbergen, M. W., Carta, F., Vullo, D., Pastoreková, S., Yaromina, A., Supuran, C. T., Dubois, L. J., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.037 · Cited by 32
Self-citationBryant, J., Gieling, R. G., Meredith, S. L., Allen, T.-J., Walker, L., Telfer, B. A., Supuran, C. T., Williams, K. J., & White, A. E. (2017) · International Journal of Cancer · doi:10.1002/ijc.31042 · Cited by 32
Self-citationExploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors
Cadoni, R., Pala, N., Lomelino, C. L., Mahon, B. P., McKENNA, R. V., Dallocchio, R. N., Dessì, A., Carcelli, M., Rogolino, D., Sanna, V., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00229 · Cited by 31
Self-citationRami, M., Cecchi, A., Montero, J., Innocenti, A., Vullo, D., Scozzafava, A., Winum, J., & Supuran, C. T. (2008) · ChemMedChem · doi:10.1002/cmdc.200800267 · Cited by 30
Self-citationInhibition of mammalian carbonic anhydrase isoforms I–XIV with a series of phenolic acid esters
Maresca, A., Akyüz, G., Osman, S. M., ALOthman, Z. A., & Supuran, C. T. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.10.014 · Cited by 29
Self-citationSteffens, M. G., Kranenborg, M. H. G. C., Boerman, O. C., et al. (1998) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1998.13.133 · Cited by 28
Coviello, V., Marchi, B., Sartini, S., Quattrini, L., Marini, A. M., Simorini, F., Taliani, S., Salerno, S., Orlandi, P., Fioravanti, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00616 · Cited by 28
Self-citationAkdemir, A., Güzel-Akdemir, Ö., Scozzafava, A., Capasso, C., & Supuran, C. T. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.029 · Cited by 26
Self-citationVitale, R. M., Alterio, V., Innocenti, A., Winum, J., Monti, S. M., Simone, G. D., & Supuran, C. T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900641r · Cited by 24
Self-citationSmaine, F.-Z., Winum, J., Montero, J., Régaı̈nia, Z., Vullo, D., Scozzafava, A., & Supuran, C. T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.019 · Cited by 24
Self-citationCarta, F., Maresca, A., Scozzafava, A., Vullo, D., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.09.003 · Cited by 24
Self-citationCarta, F., Ferraroni, M., Scozzafava, A., & Supuran, C. T. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.11.031 · Cited by 22
Self-citationKowalewska, M., Radziszewski, J., Kulik, J., Baráthová, M., Nasierowska‐Guttmajer, A., Bidziński, M., Pastorek, J., Pastoreková, S., & SIEDLECKI, J. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21106 · Cited by 21
Tumor-Associated Carbonic Anhydrases IX and XII
Ondriskova, E., Debreova, M., & Pastoreková, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63258-6.00010-x · Cited by 21
Güzel-Akdemir, Ö., Maresca, A., Scozzafava, A., Salman, A., Balaban, A. T., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.068 · Cited by 20
Self-citationBuonanno, M., Langella, E., Zambrano, N., Succoio, M., Sasso, E., Alterio, V., Fiore, A. D., Sandomenico, A., Supuran, C., Scaloni, A., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00055 · Cited by 17
Self-citationRami, M., Maresca, A., Smaine, F.-Z., Montero, J., Scozzafava, A., Winum, J., & Supuran, C. T. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.055 · Cited by 16
Self-citationCeruso, M., Antel, S., Scozzafava, A., & Supuran, C. T. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1014477 · Cited by 14
Self-citationBragagni, M., Carta, F., Osman, S. M., ALOthman, Z. A., & Supuran, C. T. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1302441 · Cited by 14
Self-citationTemperini, C., Innocenti, A., Scozzafava, A., & Supuran, C. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.105 · Cited by 11
Self-citation
Cited by
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Mishra, C. B., Tiwari, M., & Supuran, C. T. (2020) · Medicinal Research Reviews · doi:10.1002/med.21713 · Cited by 260
Self-citationMcDonald, P. C., Chia, S., Bedard, P. L., Chu, Q., Lyle, M., Tang, L., Singh, M., Zhang, Z., Supuran, C. T., Renouf, D. J., et al. (2020) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000691 · Cited by 256
Self-citation
Metadata
- Authors
- Supuran, C. T., Alterio, V., Di Fiore, A., D’ Ambrosio, K., Carta, F., Monti, S. M., & De Simone, G.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2018-04-10
- Volume
- 38
- Issue
- 6
- Pages
- 1799-1836
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2797246868
- Cited by
- 253
- References
- 200
- FWCI
- 11.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.